GlassScriptPhysician profile
Youran Gao
NPI 1881937704
$5,423.34
in general payments reported to CMS, 2019-2025
52 companies · $1,118 in 2025
The $1,118 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $403 · 2021: $477 · 2022: $953 · 2023: $1,340 · 2024: $950 · 2025: $1,118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,393 · Education: $14.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,393.31 |
| Education | $14.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,105.58 | 2020-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $562.93 | 2019-2025 | Entyvio, Eohilia |
| Janssen Biotech, INC. | $475.74 | 2022-2025 | Tremfya, Stelara, Simponi |
| Celgene Corporation | $323.78 | 2021-2024 | Zeposia |
| Novo Nordisk INC | $293.15 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $227.48 | 2020-2025 | Omvoh, Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $208.72 | 2020-2024 | Trelegy Ellipta, Nucala, Shingrix |
| Gilead Sciences, INC. | $200.77 | 2020-2025 | |
| Madrigal Pharmaceuticals | $161.74 | 2024-2025 | Rezdiffra, Resmetirom |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $149.69 | 2019-2022 | |
| Ironwood Pharmaceuticals, INC | $129.58 | 2020-2024 | Linzess |
| Merck Sharp & Dohme LLC | $126.77 | 2020-2023 | Steglatro |
| Phathom Pharmaceuticals, INC. | $113.18 | 2024-2025 | Voquezna |
| Ferring Pharmaceuticals INC. | $112.10 | 2019-2024 | Rebyota |
| Braintree Laboratories, INC. | $105.41 | 2022-2025 | Sutab, Suflave |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $99.18 | 2021-2023 | Talicia |
| Medtronic, INC. | $86.28 | 2023 | Minimed 780g |
| Amgen INC. | $74.96 | 2020-2025 | Evenity, Prolia, Uplizna |
| Recordati_rare_diseases_inc. | $62.88 | 2024 | Isturisa, Signifor Lar |
| Intercept Pharmaceuticals, INC. | $53.19 | 2022-2023 | Ocaliva |
| Xeris Pharmaceuticals, INC. | $51.53 | 2022-2025 | Recorlev |
| Lundbeck LLC | $51.43 | 2023-2024 | Rexulti |
| Pfizer INC. | $46.25 | 2023 | |
| Qol Medical, LLC | $44.74 | 2021 | |
| Ardelyx, INC. | $37.47 | 2024 | Ibsrela |
| Genzyme Corporation | $36.17 | 2023-2024 | |
| Regeneron Healthcare Solutions, INC. | $29.46 | 2022-2025 | Dupixent |
| Vivus LLC | $29.02 | 2022-2025 | Pancreaze |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.93 | 2020 | |
| Amarin Pharma, INC. | $28.81 | 2020 | |
| Abiomed | $28.24 | 2025 | |
| Corcept Therapeutics | $23.88 | 2025 | Korlym |
| Rgh Enterprises LLC | $23.73 | 2024 | |
| Exact Sciences Corporation | $18.75 | 2024 | Cologuard Collection Kit |
| Aimmune Therapeutics, INC. | $18.56 | 2025 | Zenpep |
| Baxter Healthcare | $18.31 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $18.29 | 2025 | |
| Abbott Laboratories | $17.02 | 2025 | Freestyle Libre 3 |
| Dynavax Technologies Corporation | $16.19 | 2023 | Heplisav-B |
| Sanofi Pasteur INC. | $15.45 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $15.32 | 2023 | Rexulti |
| Horizon Therapeutics Plc | $15.27 | 2023 | Krystexxa |
| Endo Pharmaceuticals INC. | $15.00 | 2022 | |
| Bausch Health US, LLC | $14.99 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.96 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.64 | 2021 | |
| Celltrion USA INC. | $14.63 | 2024 | Zymfentra |
| Astrazeneca Pharmaceuticals LP | $14.25 | 2020 | |
| Alfasigma USA, INC. | $13.80 | 2020 | |
| Olympus America INC. | $13.58 | 2025 | Hanarostent Esophagus Tts(Ccc) |
| Novartis Pharmaceuticals Corporation | $13.55 | 2024 | |
| Organon LLC | $8.01 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Youran Gao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.